D. Stewart

发表

Evaluation of cisplatin response in three radiation resistant and three radiation sensitive cell lines.

D. Wilkins, C. Ng, G. Raaphorst, 1994, Anticancer research.

Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.

S. Rosenfeld, D. Macdonald, D. Ramsay, 2000, Neuro-oncology.

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.

A. Zelenetz, D. Correa, L. Deangelis, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

E. Kimby, E. Montserrat, W. Siegert, 2003, Haematologica.

A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study

J. Dancey, D. Tu, K. Pritchard, 2001 .

Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin.

C. Ng, G. Raaphorst, D. Stewart, 1998, Oncology reports.

Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells

C. Ng, G. Raaphorst, D. Stewart, 1998, Cancer Chemotherapy and Pharmacology.

Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment.

D. Wilkins, C. Ng, G. Raaphorst, 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment

C. Ng, G. Raaphorst, L. Davis, 1996, Cancer Chemotherapy and Pharmacology.

Hydroxymethylation profile of cell-free DNA is a biomarker for early colorectal cancer

Albert J. Vilella, Casper K Lumby, Jordan M. Eizenga, 2021, Scientific Reports.

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.

L. Deangelis, J. Cairncross, S. Rosenfeld, 2006, Neuro-oncology.

High-dose Chemotherapy with Stem Cell Rescue as Initial Therapy for Anaplastic Oligodendroglioma

L. Deangelis, J. Cairncross, S. Rosenfeld, 2003, Journal of Neuro-Oncology.

Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.

S. Rosenfeld, D. Macdonald, D. Ramsay, 2000, Neuro-oncology.

A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis

D. Louis, J. Cairncross, J. Raizer, 2008, Journal of Neuro-Oncology.

Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.

E. Warner, F. Shepherd, P. Goss, 1992, Seminars in oncology.

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, Y. Cormier, G. Goss, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

T. Cascino, J. Buckner, D. Macdonald, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

E. Bruera, B. Fisher, J. Cairncross, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

J. Dancey, D. Tu, K. Pritchard, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.

C. Ng, G. Raaphorst, G. Wang, 1996, International journal of radiation biology.

A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.

E. Warner, F. Shepherd, P. Goss, 1990, Seminars in oncology.

Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.

I. Tannock, K. Bélanger, L. Seymour, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer.

S. Dahrouge, O. Agboola, G. Goss, 1999, Lung cancer.

Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

F. Shepherd, Y. Cormier, W. Steward, 1996, Lung cancer.

A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.

E. Warner, F. Shepherd, S. Dahrouge, 1992, Seminars in oncology.